Rebecca Caeser, Doreen Low, Irenaeus Chia, David Matchar, Mikael Hartman, Yi Wang, Jingmei Li, Ken Redekop, Tavintharan Subramaniam, Sharon Li Ting Pek, Hwee Lin Wee, Goh Boon Cher, Suchin Virabhak, PRECISE CIP Consortium, Shih Wee Seow, John C Chambers, Patrick Tan, Ee Shien Tan, Kar Hui Ng, Joanne Ngeow, E Shyong Tai
The Clinical Implementation Pilots (CIPs) within Singapore's National Precision Medicine (NPM) programme are designed to integrate genomic testing into clinical pathways for conditions including hereditary cancers, familial hypercholesterolemia, breast cancer, primary glomerular disease, and pharmacogenomics. These multidisciplinary pilots emphasize collaboration to enhance cost-effectiveness and improve patient outcomes, thereby establishing a sustainable foundation for future scalability in clinical genomics and ultimately fostering a healthier population through personalized healthcare solutions.